These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance. Brown JE; Del Bene VE; Collins CD Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986 [TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties. Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880 [TBL] [Abstract][Full Text] [Related]
12. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768 [TBL] [Abstract][Full Text] [Related]
13. Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic. Hikida M; Kawashima K; Nishiki K; Furukawa Y; Nishizawa K; Saito I; Kuwao S Antimicrob Agents Chemother; 1992 Feb; 36(2):481-3. PubMed ID: 1605616 [TBL] [Abstract][Full Text] [Related]
14. In vitro comparative activity of moxalactam, GR 20263, and N-formimidoyl thienamycin to other beta-lactam antibiotics and tobramycin against enterobacteriaceae and staphylococci. Cynamon MH; Granato PA Chemotherapy; 1982; 28(3):204-8. PubMed ID: 6212205 [TBL] [Abstract][Full Text] [Related]
15. Intrathecal penetration of N-formimidoyl thienamycin in normal rabbits: potentiation by coadministration of renal dipeptidase enzyme inhibitor. Chow AW; Finlay KR; Stiver HG; Carlson CL Antimicrob Agents Chemother; 1983 Apr; 23(4):634-6. PubMed ID: 6574725 [TBL] [Abstract][Full Text] [Related]
16. Comparative stability of carbapenem and penem antibiotics to renal dehydropeptidase-I. Hikida M; Yoshida M; Mitsuhashi S Arzneimittelforschung; 1993 Jan; 43(1):71-3. PubMed ID: 8447852 [TBL] [Abstract][Full Text] [Related]
17. Cilastatin-sensitive dehydropeptidase I enzymes from three sources all catalyze carbapenem hydrolysis and conversion of leukotriene D4 to leukotriene E4. Farrell CA; Allegretto NJ; Hitchcock MJ Arch Biochem Biophys; 1987 Jul; 256(1):253-9. PubMed ID: 3038022 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Rolfe RD; Finegold SM Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628 [TBL] [Abstract][Full Text] [Related]
19. Further characterization of porcine kidney aminoacylase I reveals close similarity to 'renal dipeptidase'. Heese D; Löffler HG; Röhm KH Biol Chem Hoppe Seyler; 1988 Jul; 369(7):559-66. PubMed ID: 3223987 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animals. Coleman K; Griffin DR; Upshon PA Antimicrob Agents Chemother; 1991 Sep; 35(9):1748-52. PubMed ID: 1952842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]